Quality of Life after Venous Stenting for Post-thrombotic Syndrome and the Effect of Inflow Disease.
Cross-sectional study with retrospective data collection published in Vascular and endovascular surgery (2023)
Resumen
OBJECTIVE: Patients with PTS experience an impaired quality of life (QoL). We aimed to study QoL in patients stented for post thrombotic syndrome (PTS) and analyze the influence of different parameters. METHODS: Patients stented for PTS after iliofemoral deep vein thrombosis were asked to complete the Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20) and the Short Form Health Survey (SF-36) in this cross-sectional study. All other data were collected retrospectively. Primary endpoints were median CIVIQ-20 and physical (PCS) and mental (MCS) component summary SF-36 scores. The influence of age, sex, and years between the procedure and completion of questionnaire were investigated using a multivariate linear regression model. Wilcoxon signed rank test compared the PCS and MCS with the normative. Effects of inflow from the deep femoral vein (DFV) and/or the femoral vein (FV) on QoL was analyzed in patients with patent stents. RESULTS: The response rate was 70.3% (n = 45/64). Time period (median) from stenting to questionnaire completion was 6.6 years (IQR: 8.0). Most stents were placed unilateral left-sided (73.3%). For patients with patent stents (n = 42) median CIVIQ-20 was 35.5 (IQR: 17.3), higher than the minimum of 20.0 (P < .001). Median PCS of 44.7 (IQR: 14.2) was lower (P < .001), and MCS of 55.9 (IQR: 7.1) higher (P = .001) than the normative (50.0). Time since stenting and sex were not associated with QoL. Age was a significant predictor [standardized coefficient ß = .36, P = .04] for QoL using the CIVIQ-20, but not for the SF-36. Inflow disease did not impact QoL, but patients with occluded stents (n = 3) had poor functioning levels. CONCLUSION: Quality of life is impaired after venous stenting for PTS, particularly physical functioning, among patients with an open stent, but was similar between patients with good and impaired inflow. Patients with a permanent stent occlusion had the lowest QoL.
Resumen tomado de PubMed (NCBI) para el registro citado, en el idioma original. La versión de referencia es la de la publicación original.
El resumen se deja sin traducir para conservar la redacción original de los autores.
Síntesis
Among 45 respondents stented for post-thrombotic syndrome, quality of life remained impaired, particularly physical functioning, among those with patent stents; inflow disease did not affect it, and patients with permanently occluded stents fared worst.
Por qué esto importa para la hirudoterapia
Este estudio transversal evaluó la calidad de vida en 45 de 64 pacientes elegibles (70.3% de respuesta) una mediana de 6.6 años después de la implantación de un stent venoso por síndrome postrombótico tras una trombosis venosa profunda iliofemoral, utilizando el CIVIQ-20 y el SF-36; encontró una calidad de vida persistentemente deteriorada, particularmente en la función física (resumen del componente físico mediano de 44.7 frente a un valor normativo de 50.0, p<0.001), siendo la edad un predictor significativo en el CIVIQ-20 pero la enfermedad de flujo de entrada sin mostrar ningún efecto, mientras que los tres pacientes con stents ocluidos presentaron la peor evolución. Para la ASH, documenta la morbilidad duradera que deja la tromboembolia venosa incluso después del tratamiento estructural, subrayando por qué el campo anticoagulante/antitrombótico más amplio (al que pertenece el secretoma de la sanguijuela) es clínicamente relevante. Advertencia: se trata de una encuesta transversal, retrospectiva, unicéntrica y pequeña, sin tratamiento de comparación ni relación con la terapia con sanguijuelas; describe la carga de la enfermedad, no ninguna intervención de hirudoterapia.
Citación
Quality of Life after Venous Stenting for Post-thrombotic Syndrome and the Effect of Inflow Disease.
Bakas JM et al. · Vascular and endovascular surgery, 2023
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Investigación relacionada
Más estudios revisados por pares en la categoría «Ensayos clínicos».
- Leech Therapy for Knee Osteoarthritis — The Landmark RCT — Michalsen et al. (2003)
- Leech-Assisted Flap Salvage — Systematic Review of 277 Cases — Whitaker et al. (2012)
- Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome — Bilden A et al. (2026)
- Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial — Abtahi-Forooshani M et al. (2026)
- Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report — Velasco-Bustamante J et al. (2026)
- Investigación de los efectos terapéuticos del tratamiento con sanguijuelas medicinales sobre la lesión por isquemia-reperfusión de la extremidad inferior — Ünal K et al. (2026)
- Efficacy of Medicinal Leech Therapy in Diverse Clinical Applications: A Comprehensive Study from Azerbaijan — Farzali S et al. (2025)
- HIRUDOTHERAPY IN RECONSTRUCTIVE SURGERY: CASE-REPORTS AND REVIEW — Heinz P et al. (2020)
- Hirudoterapia en la cicatrización de heridas — Nair H et al. (2022)
- Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France — Vaesken C et al. (2023)
Añadido a la biblioteca ASH: 28 de mayo de 2026 · Última actualización del sitio: 18 de junio de 2026